352 Results

People

  1. Landgren
    Landgren
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Moskowitz
    Moskowitz
  6. Younes
    Younes
  7. Abdel-Wahab
    Abdel-Wahab
  8. Dogan
    Dogan
  9. Horwitz
    Horwitz
  10. Perales
    Perales

Groups

  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (292)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Myeloma (41)
  1. "Ferrata Storti Foundation"
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (25)
  4. Editorial (15)
  5. Review (10)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (294)
  2. Hematologic Malignancies, Division of (292)
  3. Center for Hematologic Malignancies (269)
  4. Adult Leukemia (106)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Andrew Zelenetz (24)
  3. Martin Tallman (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (12)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (348)
  2. Haematologica Meeting Reports (4)
Publishers
  1. Ferrata Storti Foundation (352)

Results (352)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma
    Journal Article

    Kumar, A.; Ying, Z.; Alperovich, A.; Dogan, A.; Hamlin, P.; Moskowitz, C.; Pichardo, J.; Portlock, C.; Sha, F.; Zelenetz, A. D.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: A subset analysis from ECOG-ACRIN 1900
    Journal Article

    Fernandez, H. F.; Sun, Z.; Litzow, M. R.; Luger, S. M.; Paietta, E.; Racevskis, J.; Levine, R. L.; Patel, J. P.; Abdel-Wahab, O.; Ketterling, R. P.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors
    Journal Article

    Pulsipher, M. A.; Logan, B. R.; Kiefer, D. M.; Chitphakdithai, P.; Riches, M. L.; Rizzo, J. D.; Anderlini, P.; Leitman, O. F.; Kobusingye, H.; Besser, R. M.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: A randomized phase 2 study
    Research Letter

    Strati, P.; Fanale, M. A.; Oki, Y.; Turturro, F.; Fayad, L. E.; Bartlett, N. L.; Gladstone, D. E.; Kasamon, Y. L.; Portlock, C. S.; Wilson, W. H.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Novel iatrogenic amyloidosis caused by peptide drug liraglutide: A clinical mimic of AL amyloidosis
    Journal Article

    Martins, C. O.; Lezcano, C.; Yi, S.; Landau, H. J.; Chapman, J. R.; Dogan, A.
    Haematologica (2018)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE Trial): 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels
    Meeting Abstract

    Gambacorti-Passerini, C.; Brummendorf, T. H.; Abruzzese, E.; Rambaldi, A.; Ciceri, F.; Martino, B.; Hochhaus, A.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Long-term efficacy and cardiac, vascular and hypertension safety of bosutinib in previously treated patients with Philadelphia chromosome-positive leukemia
    Meeting Abstract

    Gambacorti-Passerini, C.; Brummendorf, T. H.; Kim, D. W.; Mauro, M. J.; Aguiar, J.; Viqueira, A.; Leip, E.; Cortes, J. E.
    Haematologica (2018)

    Fulltext@MSK | Save
  • Inhibidores de la isocitrato deshidrogenasa mutata (mIDH), ivosidenib o enasidenib, en combinación con azacitidina (AZA) en pacientes con leucemia mieloide aguda (LMA)
    Meeting Abstract

    Montesinos, P.; Di Nardo, C. D.; Stein, A. S.; Stein, E. M.; Fathi, A. T.; Schuh, A. C.; Odenike, O.; Kantarjian, H. M.; Stone, R. M.; Collins, R.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia
    Journal Article

    Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Pigneux, A.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era
    Journal Article

    Mato, A.; Jahnke, J.; Li, P.; Mehra, M.; Ladage, V. P.; Mahler, M.; Huntington, S.; Doshi, J. A.
    Haematologica (2018)

    Fulltext@MSK | Save